PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1596
https://www.valueinhealthjournal.com/article/S1098-3015(11)03158-5/fulltext
Title :
PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03158-5&doi=10.1016/j.jval.2011.08.1596
First page :
A548
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
1536